Besidens it s biodefence vaccines, Bavarian Nordic has one development programme in infectious diseases; MVA-BN® RSV. The company is seeking to establish partnerships in the early development stage once proof of concept is obtained.
MVA-BN® RSV Prophylactic vaccine, Preclinical
